> "In the United States, it's the most common reason that patients are admitted to the hospital."

Correction:  According to the Healthcare Cost and Utilization Project’s [2017 statistical brief](https://www.hcup-us.ahrq.gov/reports/statbriefs/sb225-Inpatient-US-Stays-Trends.pdf), congestive heart failure (#5), cardiac dysrhythmias (#8), and acute myocardial infarction (#10) were among the top 10 most common reasons people were admitted to US hospitals in 2014.

O coração é um dos órgãos menos regenerativos do corpo humano - um fator importante para tornar a insuficiência cardíaca a causa principal de morte em todo o mundo. E se fosse possível ajudar o músculo cardíaco a se regenerar após uma lesão? O médico e cientista Chuck Murry compartilha sua pesquisa inovadora sobre o uso de células-tronco para o crescimento de novas células cardíacas - um passo notável rumo à realização da incrível promessa de células-tronco como medicamento.

É possível regenerar o músculo cardíaco com células-tronco?

Heart disease is the world's leading killer, claiming millions of lives each year and costing over $100 billion annually in the United States alone. The human heart cannot naturally regenerate after a heart attack, leaving patients with lasting damage and declining function. New research shows that pluripotent stem cells can be transformed into heart muscle and transplanted to repair the injured heart. This advance could move heart regeneration from science fiction to everyday medicine, offering hope to millions.